These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2575759

  • 41. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
    Shannon HE.
    Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
    [Abstract] [Full Text] [Related]

  • 42. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA.
    Eur J Pharmacol; 1983 Jan 21; 86(3-4):453-9. PubMed ID: 6572591
    [Abstract] [Full Text] [Related]

  • 43. MDMA produces stimulant-like conditioned locomotor activity.
    Gold LH, Koob GF.
    Psychopharmacology (Berl); 1989 Jan 21; 99(3):352-6. PubMed ID: 2574478
    [Abstract] [Full Text] [Related]

  • 44. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH, Koob GF.
    Pharmacol Biochem Behav; 1988 Mar 21; 29(3):645-8. PubMed ID: 2896363
    [Abstract] [Full Text] [Related]

  • 45. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug 21; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 46. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH, Hubner CB, Koob GF.
    Psychopharmacology (Berl); 1989 Aug 21; 99(1):40-7. PubMed ID: 2571175
    [Abstract] [Full Text] [Related]

  • 47. Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
    Evans SM, Zacny JP, Johanson CE.
    Pharmacol Biochem Behav; 1990 Apr 21; 35(4):971-80. PubMed ID: 1971722
    [Abstract] [Full Text] [Related]

  • 48. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
    Zacny JP, Virus RM, Woolverton WL.
    Pharmacol Biochem Behav; 1990 Mar 21; 35(3):637-42. PubMed ID: 1971112
    [Abstract] [Full Text] [Related]

  • 49. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
    Herndon JL, Pierson ME, Glennon RA.
    Pharmacol Biochem Behav; 1992 Nov 21; 43(3):739-48. PubMed ID: 1333084
    [Abstract] [Full Text] [Related]

  • 50. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine.
    Kueh D, Baker LE.
    Psychopharmacology (Berl); 2007 Jan 21; 189(4):447-57. PubMed ID: 17019568
    [Abstract] [Full Text] [Related]

  • 51. MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin.
    Glennon RA, Young R.
    Pharmacol Biochem Behav; 2000 Jul 21; 66(3):483-8. PubMed ID: 10899359
    [Abstract] [Full Text] [Related]

  • 52. Stimulus effects of three sulfur-containing psychoactive agents.
    Khorana N, Pullagurla MR, Dukat M, Young R, Glennon RA.
    Pharmacol Biochem Behav; 2004 Aug 21; 78(4):821-6. PubMed ID: 15301941
    [Abstract] [Full Text] [Related]

  • 53. alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
    Glennon RA, Bondareva T, Young R.
    Pharmacol Biochem Behav; 2006 Oct 21; 85(2):448-53. PubMed ID: 17112572
    [Abstract] [Full Text] [Related]

  • 54. Methcathinone: a new and potent amphetamine-like agent.
    Glennon RA, Yousif M, Naiman N, Kalix P.
    Pharmacol Biochem Behav; 1987 Mar 21; 26(3):547-51. PubMed ID: 3575369
    [Abstract] [Full Text] [Related]

  • 55. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.
    Hubner CB, Bird M, Rassnick S, Kornetsky C.
    Psychopharmacology (Berl); 1988 Mar 21; 95(1):49-51. PubMed ID: 2898790
    [Abstract] [Full Text] [Related]

  • 56. Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
    Young R, Khorana N, Bondareva T, Glennon RA.
    Pharmacol Biochem Behav; 2005 Oct 21; 82(2):404-10. PubMed ID: 16253319
    [Abstract] [Full Text] [Related]

  • 57. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME.
    J Neurosci; 1988 Aug 21; 8(8):2788-803. PubMed ID: 2457659
    [Abstract] [Full Text] [Related]

  • 58. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA, Hauck AE.
    Pharmacol Biochem Behav; 1985 Dec 21; 23(6):937-41. PubMed ID: 2934750
    [Abstract] [Full Text] [Related]

  • 59. Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.
    Glennon RA, Young R, Rangisetty JB.
    Pharmacol Biochem Behav; 2002 May 21; 72(1-2):379-87. PubMed ID: 11900809
    [Abstract] [Full Text] [Related]

  • 60. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA, Peroutka SJ.
    Neurosci Lett; 1988 Dec 19; 95(1-3):208-12. PubMed ID: 2906416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.